Brought to you by 
CardioDx, GE pen cardiovascular diagnostics alliance
28 Jun 2019
Executive Summary
Concurrent with a $5mm investment in CardioDx Inc.'s (cardiovascular tests) ongoing $34.6mm Series D venture round, GE Healthcare has signed an alliance with the company to co-develop cardiovascular disease diagnostics.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CardioDx, GE pen cardiovascular diagnostics alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice